PlainRecalls
FDA Drug Low Class III Terminated

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88) and c) 500 (NDC 47335-737-13) count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India

Reported: February 1, 2017 Initiated: December 20, 2016 #D-0445-2017

Product Description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88) and c) 500 (NDC 47335-737-13) count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India

Reason for Recall

Failed Dissolution Specifications; 18 month stability time point

Details

Units Affected
a) 141,068 bottles b) 56,834 bottles c) 61,692 bottles
Distribution
Nationwide
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88) and c) 500 (NDC 47335-737-13) count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India. Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: a) 141,068 bottles b) 56,834 bottles c) 61,692 bottles.
Why was this product recalled?
Failed Dissolution Specifications; 18 month stability time point
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Low. Recall number: D-0445-2017.